University of Medicine and Dentistry of New Jersey
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, University of Medicine and Dentistry of New Jersey sits in the top decile of US sponsors by registered trial count (#265 of 15,742 sponsors by registered trial count).
University of Medicine and Dentistry of New Jersey: 88 sponsored US clinical trials, none currently recruiting.
University of Medicine and Dentistry of New Jersey sponsors 88 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 56 completed. 14 of these trials are in Phase 3-4 (later-stage) and 36 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 2 trials.
Top-decile sponsor footprint
University of Medicine and Dentistry of New Jersey ranks in the top decile of sponsors by registered trial count (#265 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
56 of 88 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (63.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
88 total, page 2 of 2
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease
NCT00176475
Assessment of the Clinical Utility of Non Invasive Peripheral Signal Averaged Pulse Volume
NCT00143858
The Use of HEMOBAG to Salvage Blood After Cardiac Surgery
NCT00176657
Pathogen Specific Immunity in Patients With Sarcoidosis
NCT00217789
Heart Rate and Blood Pressure Response During Exercise and Sexual Activity in Normotensive and Hypertensive Volunteers
NCT00143988
Galantamine Versus Placebo in Childhood Autism
NCT00252603
The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon
NCT00176618
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety
NCT00177008
A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35
NCT00161226
A GameBoy as a Distraction Before Surgery in Children
NCT00176670
Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
NCT00101062
Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
NCT00118131
Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo
NCT00134368
Transitioning From Cyclosporine to Alefacept in Psoriasis
NCT00143806
Ischemic Preconditioning of Liver in Cadaver Donors
NCT00245830
Dextromethorphan in Treating Patients With Fatigue Caused by Cancer
NCT00176540
Alefacept Mechanism of Action in Psoriasis
NCT00150982
A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia
NCT00176566
Effect of Vitamins on Academic Performance of School Children
NCT00418990
Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer
NCT00176579
Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
NCT00176488
A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity
NCT00176553
Comparison of Three Electroconvulsive Therapy (ECT) Techniques for the Treatment of Major Depression
NCT00069407
Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI
NCT00176592
Massage Therapy for Osteoarthritis of the Knee
NCT00322244
Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor
NCT00161200
Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
NCT00176527
Internet Use Among Women With Recurrent Metastatic Breast Cancer
NCT00770055
Quality of Life in Children With HIV Infection
NCT00075153
Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction
NCT00707187
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
NCT00161187
Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer
NCT00138151
Treatment of Medically Unexplained Physical Ailments (Somatization Disorder)
NCT00050583
Expression of Tuberculosis in the Lung
NCT00201253
A Pilot Trial to Assess the Effects of Green Tea in the Prevention of Therapy-Induced Mucositis
NCT00176514
Cognitive Behavior Therapy for Somatization Disorder
NCT00276887
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
NCT00004058
Sulindac and Plant Compounds in Preventing Colon Cancer
NCT00003365
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 14 |
| Phase 2 | 22 |
| Phase 3 | 7 |
| Phase 4 | 7 |
Therapeutic Areas
How the University of Medicine and Dentistry of New Jersey early-phase archive is shaped
88 indexed studies, none listed as recruiting (0% open); 56 completed (64%).
Phase mix: 14 late (III/IV) vs 36 early (I/II) (early-phase heavy).
Top condition: Depression (2 trials), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
University of Medicine and Dentistry of New Jersey: archived-pipeline peers nationwide
Peers matched on 88 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
University of Medicine and Dentistry of New Jersey sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 88 archived trials
- AbbVie (prior sponsor, Abbott) · 88 trials · 0% recruiting
- Pacira Pharmaceuticals · 88 trials · 6% recruiting
- Abbott Nutrition · 89 trials · 1% recruiting
- Florida International University · 89 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this University of Medicine and Dentistry of New Jersey page
88 registered trials is a research-attention snapshot, not an endorsement of University of Medicine and Dentistry of New Jersey or any single study.
- None of University of Medicine and Dentistry of New Jersey's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Depression is the condition University of Medicine and Dentistry of New Jersey studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Medicine and Dentistry of New Jersey pipeline card: 88 registered trials from official public datasets.Report a data error.